AATD

Clinical trials for AATD explained in plain language.

Never miss a new study

Get alerted when new AATD trials appear

Sign up with your email to follow new studies for AATD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

Experimental KRRO-110 trial for rare lung condition halted early

Disease control Terminated

This study tested an experimental drug called KRRO-110 in healthy volunteers and people with Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can cause lung and liver damage. The goal was to check safety and how the drug moves through the body. However, the trial w…

Matched conditions: AATD

Phase: PHASE1, PHASE2 • Sponsor: Korro Bio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

AATD

Get alerted when new AATD trials appear

Experimental KRRO-110 trial for rare lung condition halted early